OxyContin Settlement: Will drug makers think twice?

Last month, the makers of Oxycontin, Purdue Pharma, reached an agreement worth over $635 million to resolve criminal charges stemming from their false marketing regarding the risk of addiction associated with the painkiller.  A large portion of the profits the company generated while mislabeling their drug… Read More

Harvey Kirk

By
June 25, 2007 | 2 Comments

Avandia heart failure black box warning

During congressional hearings on Wednesday, FDA officials indicated that they intend to ask drug makers to add a new 'black box' warning to Avandia and Actos.  The warning will highlight the increased risk of heart failure associated with the two drugs which are used to treat… Read More

Harvey Kirk

By
June 11, 2007 | 1 Comment

OxyContin lawsuits still being reviewed nationwide

UPDATE 9/4/2007: Saiontz & Kirk, P.A. is no longer reviewing potential new OxyContin lawsuits.  Earlier this month, a criminal investigation concluded with the makers of OxyContin pleading guilty to misdemeanor violations of misbranding the drug by actively minimizing the risk of addiction to increase profits, even at… Read More

Harvey Kirk

By
May 30, 2007 | 5 Comments

Exjade kidney problems leads to FDA warning

The FDA and drug maker Novartis AG have issued an important warning about problems with Exjade which could lead to kidney failure or death.  Information about Exjade side effects were outlined in a May 14, 2007 letter to healthcare providers which was posted on the FDA… Read More

Harvey Kirk

By
May 22, 2007 | 3 Comments